Innovating Works

TLS

Desconocido
PROACTIVE: PROposing Action to ConTrol and Impede betacoronaVirus Emergencies FONDAZIONE TOSCANA LIFE SCIENCES tramitó un HORIZON EUROPE ERC-2022-ADG The COVID-19 pandemic caught the world unprepared. Vaccines and monoclonal antibodies (mAbs), developed in record time, mitigated the health...
2023-10-31 - 2028-10-31 | Financiado
ArTCell: Bottom-up manufacturing of artificial anti-tumor T cells FONDAZIONE TOSCANA LIFE SCIENCES participó en un HORIZON EUROPE HORIZON-EIC-2023-PATHFINDEROPEN-01 T cells play a central role in anti-tumor immune protection. While their ability to target and eliminate emerging tumor cells is increasingl...
2023-10-09 - 2029-01-31 | Financiado
MammoScreen: Innovative and safe microwave-based imaging technology to make breast cancer screening more accurate... FONDAZIONE TOSCANA LIFE SCIENCES tramitó un HORIZON EUROPE HORIZON-MISS-2021-CANCER-02 Breast cancer (BC) is the most common cancer in women worldwide, affecting 1 in 8 women. The figures from WHO’s International Agency for Res...
2022-11-28 - 2026-11-30 | Financiado
BornToGetThere: Implementation of early detection and early intervention service delivery in infants at risk for cer... FONDAZIONE TOSCANA LIFE SCIENCES participó en un H2020 H2020-SC1-BHC-2018-2020 Despite advances in the medical management of high-risk pregnancies and deliveries, cerebral palsy (CP) remains the most common physical dis...
2019-12-10 - 2024-12-31 | Financiado
SINO-EU-PerMed: Widening Sino EU policy and research cooperation in Personalised Medicine FONDAZIONE TOSCANA LIFE SCIENCES participó en un H2020 H2020-SC1-BHC-2018-2020 Personalised Medicine (PerMed) approaches bring along immense potentials to improve diagnosis and treatment of diseases and prevention strat...
2019-12-02 - 2024-06-30 | Financiado
VACCIBIOME: Cancer Vaccines and Gut Microbiome a rational approach to optimize cancer immunotherapy FONDAZIONE TOSCANA LIFE SCIENCES participó en un H2020 ERC-2018-ADG This proposal intends to shed light on the interplay between cancer immunity and gut microbiome as a way to optimize personalized cancer vac...
2019-06-04 - 2024-08-31 | Financiado
REGIONS4PERMED: INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH FONDAZIONE TOSCANA LIFE SCIENCES tramitó un H2020 H2020-SC1-BHC-2018-2020 Personalised medicine (PM) represents a paradigm shift away from a ‘one size fits all’ approach to the treatment and care of patients with a...
2018-10-19 - 2023-04-30 | Financiado
vAMRes: Vaccines as a remedy for antimicrobial resistant bacterial infections FONDAZIONE TOSCANA LIFE SCIENCES tramitó un H2020 ERC-2017-ADG Antimicrobial Resistance (AMR) is perhaps the most emerging alarm in health. It already causes 700,000 deaths per year and the forecast for...
2018-09-04 - 2023-10-31 | Financiado
OMVCRC: Engineered bacterial Outer Membrane Vesicles OMVs for colorectal cancer immunotherapy FONDAZIONE TOSCANA LIFE SCIENCES participó en un H2020 ERC-2017-PoC This proposal originates from recent results obtained in the course of the Advanced ERC Project OMVac, the scope of which is to exploit the...
2017-11-07 - 2019-06-30 | Financiado
TRANSCAN-2: ERA NET Aligning national regional translational cancer research programmes and activities Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being...
2014-12-01 - 2021-06-30 | Financiado
NERRI: Neuro Enhancement Responsible Research and Innovation FONDAZIONE TOSCANA LIFE SCIENCES participó en un FP7 This project aims to contribute to the introduction of Responsible Research and Innovation in neuro-enhancement (NE) in the European Researc...
Financiado
EPISODE: Exploiting the Potential of Structural Biology through NMR and Associated Technologies Opportuniti... FONDAZIONE TOSCANA LIFE SCIENCES participó en un FP7 EPISODE’s goal is to maximize the regional benefits of Structural Biology Research Infrastructures in NMR and associated technologies for th...
Financiado
OMVAC: Outer Membrane Vesicles OMVs from Vaccinobacter A Synthetic Biology approach for effective vacc... FONDAZIONE TOSCANA LIFE SCIENCES participó en un FP7 This proposal intends to apply Synthetic Biology to create a new bacterial species, Vaccinobacter, devoted to the production of multivalent,...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.